A Lifestyle Approach for Primary Cardiovascular Disease Prevention in Perimenopausal to Early Postmenopausal Women

American Journal of Lifestyle Medicine

Volumn 2, Issue 5, 2008, Pages 421-431

  Pettee, Kelley K ^a   Storti, Kristi L ^b   Conroy, Molly B ^b   Ainsworth, Barbara E ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

diet; exercise; heart disease; lifestyle intervention; menopause; physical activity; risk factors

Indexed keywords

EID: 84992792281     PISSN: 15598276     EISSN: None     Source Type: Journal    
DOI: 10.1177/1559827608320132     Document Type: Review

References (67)

1. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007; 115: e69-e171.
2. American Heart Association. Heart Disease and Stroke Statistics-2005 Update. Dallas, TX: American Heart Association; 2004.
3. Mosca L., Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007; 115: 1481-1501.
4. Albert CM, Chae CU, Grodstein F., et al. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003; 107: 2096-2101.
5. Soules MR, Sherman S., Parrott E., et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric. 2001; 4: 267-272.
6. Research on the menopause in the 1990s: report of a WHO Scientific Group. World Health Organ Tech Rep Ser. 1996;866: 1-107.
7. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med. 2005; 142(pt 1):1003-1013.
8. Carr MC The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003; 88: 2404-2411.
9. Douchi T., Yamamoto S., Nakamura S., et al. The effect of menopause on regional and total body lean mass. Maturitas. 1998; 29: 247-252.
10. Svendsen OL, Hassager C., Christiansen C. Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism. 1995; 44: 369-373.
11. Tremollieres FA, Pouilles JM, Ribot CA Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol. 1996; 175: 1594-1600.
12. Morita Y., Iwamoto I., Mizuma N., et al. Precedence of the shift of body-fat distribution over the change in body composition after menopause. J Obstet Gynaecol Res. 2006; 32: 513-516.
13. Ley CJ, Lees B., Stevenson JC Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr. 1992; 55: 950-954.
14. Misso ML, Jang C., Adams J., et al. Differential expression of factors involved in fat metabolism with age and the menopause transition. Maturitas. 2005; 51: 299-306.
15. Sowers M., Zheng H., Tomey K., et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab. 2007; 92: 895-901.
16. Kannel WB, Cupples LA, Ramaswami R., Stokes J. III, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol. 1991; 44: 183-190.
17. Despres JP Abdominal obesity as important component of insulin-resistance syndrome. Nutrition. 1993; 9: 452-459.
18. Matthews KA, Kuller LH, Sutton-Tyrrell K., Chang YF Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke. 2001; 32: 1104-1111.
19. Grodstein F., Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis. 1995; 38: 199-210.
20. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998; 280: 605-613.
21. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288: 321-333.
22. Anderson GL, Limacher M., Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291:1701-1712.
23. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial JAMA. 1995; 273: 199-208.
24. Hersh AL, Stefanick ML, Stafford RS National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004; 291: 47-53.
25. Majumdar SR, Almasi EA, Stafford RS Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA. 2004;292:1983-1988.
26. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force Ann Intern Med. 2005; 142: 855-860.
27. US Department of Health and Human Services. Surgeon General's Report on Physical Activity and Health. Washington, DC: Government Printing Office; 1996.
28. Thompson PD Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003; 23: 1319-1321.
29. Powell KE, Thompson PD, Caspersen CJ, Kendrick JS Physical activity and the incidence of coronary heart disease. Annu Rev Public Health. 1987; 8: 253-287.
30. Berlin JA, Colditz GA A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1990; 132: 612-628.
31. Kushi LH, Fee RM, Folsom AR, Mink PJ, Anderson KE, Sellers TA Physical activity and mortality in postmenopausal women. JAMA. 1997; 277: 1287-1292.
32. Manson JE, Hu FB, Rich-Edwards JW, et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med. 1999; 341: 650-658.
33. Lee IM, Rexrode KM, Cook NR, Manson JE, Buring JE Physical activity and coronary heart disease in women: is “no pain, no gain” passé? JAMA. 2001; 285: 1447-1454.
34. Manson JE, Greenland P., LaCroix AZ, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 2002; 347: 716-725.
35. Carroll S., Dudfield M. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome. Sports Med. 2004;34: 371-418.
36. Press V., Freestone I., George CF Physical activity: the evidence of benefit in the prevention of coronary heart disease. QJM. 2003; 96: 245-251.
37. Powers SK, Howley ET Exercise Physiology: Theory and Application to Fitness and Performance. 4th ed. Boston: McGraw-Hill; 2001.
38. Bouchard C. Physical Activity and Prevention of Cardiovascular Disease. Champaign, IL: Human Kinetics; 1997.
39. Bouchard C., Depres JP, Tremblay A. Exercise and obesity. Obes Res. 1993; 1: 133-147.
40. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS). Available at: www.cdc.gov/brfss. Accessed September 29, 2006.
41. US Department of Health and Human Services. Health behaviors of adults: United States, 1999-2001. Vital Health Stat. 2004; 10: 39-53.
42. Pate RR, Pratt M., Blair SN, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995; 273: 402-407.
43. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-2497.
44. Knowler WC, Barrett-Connor E., Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346: 393-403.
45. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997; 20: 537-544.
46. Erikkson KF, Lindgärde F. Prevention of type 2 (non-insulin dependent) diabetes mellitus by diet and physical activity. Diabetologia. 1991; 34: 891-898.
47. Tuomilehto J., Lindstrom J., Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344: 1343-1350.
48. Ornish D., Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280:2001-2007.
49. Simkin-Silverman L., Wing RR, Hansen DH, et al. Prevention of cardiovascular risk factor elevations in healthy premenopausal women. Prev Med. 1995; 24: 509-517.
50. Simkin-Silverman LR, Wing RR, Boraz MA, Meilahn EN, Kuller LH Maintenance of cardiovascular risk factor changes among middle-aged women in a lifestyle intervention trial. Women's Health. 1998; 4: 255-271.
51. Kuller LH, Simkin-Silverman LR, Wing RR, Meilahn EN, Ives DG Women's Healthy Lifestyle Project: a randomized clinical trial-results at 54 months. Circulation. 2001; 103: 32-37.
52. Simkin-Silverman LR, Wing RR, Boraz MA, Kuller LH Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial. Ann Behav Med. 2003; 26: 212-220.
53. Kuller LH, Kinzel LS, Pettee KK, et al. Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN Study) clinical trial. J Women's Health. 2006; 15: 964-976.
54. Mosca L., Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004; 109: 672-693.
55. Mosca L., Manson JE, Sutherland SE, Langer RD, Manolio T., Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1997; 96: 2468-2482.
56. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL Weight gain at the time of menopause. Arch Intern Med. 1991; 151: 97-102.
57. We the People: Women and Men in the United States. Washington, DC: US Census Bureau; 2005.
58. Hayes SN Preventing cardiovascular disease in women. Am Fam Physician. 2006; 74: 1331-1340.
59. Mosca L., Ferris A., Fabunmi R., Robertson RM Tracking women's awareness of heart disease: an American Heart Association national study. Circulation. 2004; 109: 573-579.
60. Mosca L., Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005; 111: 499-510.
61. Mosca L., Mochari H., Christian A., et al. National study of women's awareness, preventive action, and barriers to cardiovascular health. Circulation. 2006; 113: 525-534.
62. American Heart Association. Go Red for Women. Available at: www.goredforwomen.org. Accessed July 23, 2007.
63. Hing E., Cherry DK, Woodwell DA National Ambulatory Medical Care Survey: 2003 summary. Adv Data. 2005; 365: 1-48.
64. Yarnall KS, Pollak KI, Ostbye T., Krause KM, Michener JL Primary care: is there enough time for prevention? Am J Public Health. 2003; 93: 635-641.
65. Glasgow RE, Emont S., Miller DC Assessing delivery of the five ‘As’ for patient-centered counseling. Health Promot Int. 2006; 21: 245-255.
66. American Heart Association: Choose to Move. Available at: http://www.choosetomove.org/. Accessed July 23, 2007.
67. Kuller LH, Simkin-Silverman LR, Wing RR, Meilahn EN, Ives DG Women's Healthy Lifestyle Project: a randomized clinical trial: results at 54 months. Circulation. 2001; 103: 32-37.